Stay updated on Ramucirumab vs Docetaxel in Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the Ramucirumab vs Docetaxel in Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ramucirumab vs Docetaxel in Bladder Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.0 to v2.14.1.
    Difference
    0.0%
    Check dated 2025-01-19T23:55:52.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.
    Difference
    0.1%
    Check dated 2025-01-12T18:48:13.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    No Change Detected
  6. Check
    39 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.0%
    Check dated 2024-12-14T22:55:08.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the location details.
    Difference
    1%
    Check dated 2024-12-07T16:30:51.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    Several key resources related to genetics and cancer, including MedlinePlus and NIH links, have been removed, which may impact access to important health information.
    Difference
    3%
    Check dated 2024-11-23T04:59:34.000Z thumbnail image
  9. Check
    68 days ago
    Change Detected
    Summary
    New resources related to bladder cancer, transitional cell carcinoma, and urethral cancer have been added, along with links to drug information and various health organizations.
    Difference
    0.3%
    Check dated 2024-11-16T00:04:00.000Z thumbnail image

Stay in the know with updates to Ramucirumab vs Docetaxel in Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ramucirumab vs Docetaxel in Bladder Cancer Clinical Trial page.